
Gerald R. Ewoldt
Examiner (ID: 4358, Phone: (571)272-0843 , Office: P/1644 )
| Most Active Art Unit | 1644 |
| Art Unit(s) | 1644 |
| Total Applications | 1060 |
| Issued Applications | 256 |
| Pending Applications | 142 |
| Abandoned Applications | 661 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 62289
[patent_doc_number] => 07763251
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-07-27
[patent_title] => 'Kits to assess the risk of tumor progression'
[patent_app_type] => utility
[patent_app_number] => 11/474144
[patent_app_country] => US
[patent_app_date] => 2006-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 23382
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/763/07763251.pdf
[firstpage_image] =>[orig_patent_app_number] => 11474144
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/474144 | Kits to assess the risk of tumor progression | Jun 22, 2006 | Issued |
Array
(
[id] => 4999339
[patent_doc_number] => 20070041973
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-22
[patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING, PREVENTING AND/OR REVERSING TYPE-1 DIABETES'
[patent_app_type] => utility
[patent_app_number] => 11/425084
[patent_app_country] => US
[patent_app_date] => 2006-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 22222
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0041/20070041973.pdf
[firstpage_image] =>[orig_patent_app_number] => 11425084
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/425084 | Methods and compositions reversing pre-diabetes using fusion proteins comprising a GAD peptide | Jun 18, 2006 | Issued |
Array
(
[id] => 6372658
[patent_doc_number] => 20100080792
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-01
[patent_title] => 'Method for Identifying a MHC Class II-Dependent Tumor-Associated T Helper Cell Antigen'
[patent_app_type] => utility
[patent_app_number] => 11/917363
[patent_app_country] => US
[patent_app_date] => 2006-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 13160
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0080/20100080792.pdf
[firstpage_image] =>[orig_patent_app_number] => 11917363
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/917363 | Method for Identifying a MHC Class II-Dependent Tumor-Associated T Helper Cell Antigen | Jun 14, 2006 | Abandoned |
Array
(
[id] => 5050900
[patent_doc_number] => 20070031445
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-08
[patent_title] => 'Compositions and methods for enhancing immune responses mediated by antigen-presenting cells'
[patent_app_type] => utility
[patent_app_number] => 11/451739
[patent_app_country] => US
[patent_app_date] => 2006-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 19636
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0031/20070031445.pdf
[firstpage_image] =>[orig_patent_app_number] => 11451739
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/451739 | Compositions and methods for enhancing immune responses mediated by antigen-presenting cells | Jun 12, 2006 | Abandoned |
Array
(
[id] => 6280226
[patent_doc_number] => 20100119489
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-13
[patent_title] => 'Stimulation of Pancreatic Beta Cell Proliferation'
[patent_app_type] => utility
[patent_app_number] => 11/921923
[patent_app_country] => US
[patent_app_date] => 2006-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 13719
[patent_no_of_claims] => 75
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0119/20100119489.pdf
[firstpage_image] =>[orig_patent_app_number] => 11921923
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/921923 | Stimulation of Pancreatic Beta Cell Proliferation | Jun 6, 2006 | Abandoned |
Array
(
[id] => 4970757
[patent_doc_number] => 20070110759
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-17
[patent_title] => 'Methods'
[patent_app_type] => utility
[patent_app_number] => 11/434320
[patent_app_country] => US
[patent_app_date] => 2006-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 33
[patent_no_of_words] => 20483
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0110/20070110759.pdf
[firstpage_image] =>[orig_patent_app_number] => 11434320
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/434320 | Methods | May 10, 2006 | Abandoned |
Array
(
[id] => 5601782
[patent_doc_number] => 20060292127
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-28
[patent_title] => 'Beta cell growth and differentiation'
[patent_app_type] => utility
[patent_app_number] => 11/429164
[patent_app_country] => US
[patent_app_date] => 2006-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 9520
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0292/20060292127.pdf
[firstpage_image] =>[orig_patent_app_number] => 11429164
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/429164 | Beta cell growth and differentiation | May 4, 2006 | Abandoned |
Array
(
[id] => 5851119
[patent_doc_number] => 20060234310
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-19
[patent_title] => 'Enriched antigen-specific T-cells and related therapeutic and prophylactic compositions and methods'
[patent_app_type] => utility
[patent_app_number] => 11/415135
[patent_app_country] => US
[patent_app_date] => 2006-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 4944
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0234/20060234310.pdf
[firstpage_image] =>[orig_patent_app_number] => 11415135
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/415135 | Enriched antigen-specific T-cells and related therapeutic and prophylactic compositions and methods | Apr 30, 2006 | Abandoned |
Array
(
[id] => 5075234
[patent_doc_number] => 20070015209
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-18
[patent_title] => 'Compositions and methods for diagnosing, predicting therapeutic response of, and monitoring autoimmune disease'
[patent_app_type] => utility
[patent_app_number] => 11/406156
[patent_app_country] => US
[patent_app_date] => 2006-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 26361
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0015/20070015209.pdf
[firstpage_image] =>[orig_patent_app_number] => 11406156
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/406156 | Compositions and methods for diagnosing, predicting therapeutic response of, and monitoring autoimmune disease | Apr 17, 2006 | Issued |
Array
(
[id] => 9311272
[patent_doc_number] => 08652488
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-02-18
[patent_title] => 'Insulin B chain autoantigen composition'
[patent_app_type] => utility
[patent_app_number] => 11/403580
[patent_app_country] => US
[patent_app_date] => 2006-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13831
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11403580
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/403580 | Insulin B chain autoantigen composition | Apr 12, 2006 | Issued |
Array
(
[id] => 5921425
[patent_doc_number] => 20060240032
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-26
[patent_title] => 'Immunomodulating compositions and methods for use in the treatment of human autoimmune diseases'
[patent_app_type] => utility
[patent_app_number] => 11/395663
[patent_app_country] => US
[patent_app_date] => 2006-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 10486
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0240/20060240032.pdf
[firstpage_image] =>[orig_patent_app_number] => 11395663
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/395663 | Immunomodulating compositions and methods for use in the treatment of human autoimmune diseases | Mar 29, 2006 | Abandoned |
Array
(
[id] => 8188881
[patent_doc_number] => 08183039
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-05-22
[patent_title] => 'Method for isolating BDCA-4+ dendritic cells'
[patent_app_type] => utility
[patent_app_number] => 11/393155
[patent_app_country] => US
[patent_app_date] => 2006-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 24
[patent_no_of_words] => 34498
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/183/08183039.pdf
[firstpage_image] =>[orig_patent_app_number] => 11393155
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/393155 | Method for isolating BDCA-4+ dendritic cells | Mar 28, 2006 | Issued |
Array
(
[id] => 5264453
[patent_doc_number] => 20090117138
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-07
[patent_title] => 'VACCINE FOR A THERAPEUTIC OR A PROPHYLACTIC TREATMENT OF MYASTHENIA GRAVIS'
[patent_app_type] => utility
[patent_app_number] => 12/294109
[patent_app_country] => US
[patent_app_date] => 2006-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 7734
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0117/20090117138.pdf
[firstpage_image] =>[orig_patent_app_number] => 12294109
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/294109 | Vaccine for a therapeutic or a prophylactic treatment of myasthenia gravis | Mar 22, 2006 | Issued |
Array
(
[id] => 5618940
[patent_doc_number] => 20060188473
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-24
[patent_title] => 'Compositions and methods for repressing B cell autoantibody secretion and for treating autoimmune disorders'
[patent_app_type] => utility
[patent_app_number] => 11/376375
[patent_app_country] => US
[patent_app_date] => 2006-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 27270
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 25
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0188/20060188473.pdf
[firstpage_image] =>[orig_patent_app_number] => 11376375
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/376375 | Methods for repressing B cell autoantibody secretion and for treating autoimmune disorders by administration of hematopoietic stem cells and macrophage-colony stimulating factor | Mar 14, 2006 | Issued |
Array
(
[id] => 4909145
[patent_doc_number] => 20080019911
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-24
[patent_title] => 'Method for decreasing blood glucose and improving glucose tolerance using angiopoietin-like protein 4'
[patent_app_type] => utility
[patent_app_number] => 11/375297
[patent_app_country] => US
[patent_app_date] => 2006-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 5093
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0019/20080019911.pdf
[firstpage_image] =>[orig_patent_app_number] => 11375297
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/375297 | Method for decreasing blood glucose and improving glucose tolerance using angiopoietin-like protein 4 | Mar 13, 2006 | Abandoned |
Array
(
[id] => 5141327
[patent_doc_number] => 20070003543
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-04
[patent_title] => 'Low dose histone peptide treatment for autoimmune disorders'
[patent_app_type] => utility
[patent_app_number] => 11/373894
[patent_app_country] => US
[patent_app_date] => 2006-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 86
[patent_figures_cnt] => 86
[patent_no_of_words] => 40168
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20070003543.pdf
[firstpage_image] =>[orig_patent_app_number] => 11373894
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/373894 | Low dose histone peptide treatment for autoimmune disorders | Mar 12, 2006 | Abandoned |
Array
(
[id] => 5564632
[patent_doc_number] => 20090137485
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-28
[patent_title] => 'Antigens Targeted by Pathogenic T Cells in Type 1 Diabetes and Uses Thereof'
[patent_app_type] => utility
[patent_app_number] => 11/886482
[patent_app_country] => US
[patent_app_date] => 2006-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 10688
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0137/20090137485.pdf
[firstpage_image] =>[orig_patent_app_number] => 11886482
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/886482 | Antigens Targeted by Pathogenic T Cells in Type 1 Diabetes and Uses Thereof | Mar 8, 2006 | Abandoned |
Array
(
[id] => 5682958
[patent_doc_number] => 20060199228
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-07
[patent_title] => 'Peptides for treatment of autoimmune diseases'
[patent_app_type] => utility
[patent_app_number] => 11/370168
[patent_app_country] => US
[patent_app_date] => 2006-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 10889
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0199/20060199228.pdf
[firstpage_image] =>[orig_patent_app_number] => 11370168
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/370168 | Peptides for treatment of autoimmune diseases | Mar 7, 2006 | Abandoned |
Array
(
[id] => 4682785
[patent_doc_number] => 20080249011
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-09
[patent_title] => 'Use of Mgc4504'
[patent_app_type] => utility
[patent_app_number] => 11/908065
[patent_app_country] => US
[patent_app_date] => 2006-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 14710
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0249/20080249011.pdf
[firstpage_image] =>[orig_patent_app_number] => 11908065
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/908065 | Use of Mgc4504 | Mar 5, 2006 | Abandoned |
Array
(
[id] => 5682569
[patent_doc_number] => 20060198839
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-07
[patent_title] => 'Methods and pharmaceutical compositions for treating type 1 diabetes mellitus and other conditions'
[patent_app_type] => utility
[patent_app_number] => 11/367682
[patent_app_country] => US
[patent_app_date] => 2006-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11527
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0198/20060198839.pdf
[firstpage_image] =>[orig_patent_app_number] => 11367682
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/367682 | Methods and pharmaceutical compositions for treating type 1 diabetes mellitus and other conditions | Mar 2, 2006 | Issued |